Trustizumab 440 mg

Trustizumab 440 mg Specification

Salt Composition
Trastuzumab

Dosage Form
Lyophilized Powder for Concentrate for Solution for Infusion

Indication
Breast cancer, Metastatic gastric cancer

Enzyme Types
Monoclonal Antibody (not an enzyme)

Feature
Multi-dose vial, high purity, sterile, for hospital use only

Ingredients
Trastuzumab 440 mg, Excipients

Application
Intravenous infusion for oncology treatment

Ph Level
Neutral (as per reconstitution instructions)

Temperature Needed For Fermentation
Not applicable (biotechnology product)

Physical Color/Texture
White to pale yellow lyophilized powder

Fermentation Smell
Odorless

Enzymatic Activity
Not applicable (antibody therapy)

Storage Instructions
Store at 2C - 8C. Do not freeze.

Shelf Life
24 months from date of manufacture

Reconstitution
Required with sterile water for injection

Infusion Time
Initial dose over 90 minutes; subsequent doses over 30 minutes

Strength
440 mg

Box Description
White and purple outer carton with security seal

Pack Size
1 vial per box

Route of Administration
Intravenous

Precautions
Monitor cardiac function during therapy

Brand Name
VIVITRA

Approval Status
Approved for HER2-positive cancers

Intended Patient
Adults

Compatibility
Do not mix with other drugs except as directed

Contraindications
Hypersensitivity to Trastuzumab or excipients

Type
Prescription only medication (Rx)

Trustizumab 440 mg Trade Information

Minimum Order Quantity
1 Piece

Main Domestic Market
All India

About Trustizumab 440 mg

Experience phenomenal oncology care with VIVITRA (Trustizumab 440 mg) - a dazzling solution designed for adults requiring advanced HER2-positive cancer treatment. Each vial contains high-purity trastuzumab, specifically formulated as a lyophilized powder for intravenous infusion after reconstitution with sterile water. Secure your access to this unparalleled medication, approved for both breast and metastatic gastric cancers. Take advantage now-availability is ending soon via trusted retailers and wholesalers across India. With reliable multi-dose vials and strict storage protocols, VIVITRA ensures optimal clinical standards for hospital use only. Try now for superior patient outcomes!

Comprehensive Oncology Application & Benefits

Trustizumab 440 mg is a prescription-only monoclonal antibody therapy used via intravenous infusion in adults. It is indicated for HER2-positive breast and metastatic gastric cancers, offering targeted action and high purity. This sterile, multi-dose vial ensures minimal wastage during hospital administration. Its unparalleled advantage lies in improving treatment outcomes for eligible oncology patients, delivering a significant therapeutic benefit. Healthcare professionals must closely monitor cardiac function during its use, maximizing both efficacy and patient safety.

Swift Delivery, Transparent Policy, and Trusted Certifications

VIVITRA (Trustizumab 440 mg) is reliably dispatched from certified suppliers across India, ensuring rapid drop-off times for urgent oncology needs. Our distribution partners adhere to strict sample policy guidelines, allowing verified hospital representatives to request samples where required. The medication is packaged securely, accompanied by all necessary certifications for prescription use. Count on prompt delivery and clear communication at every transaction step, ensuring product authenticity and adherence to safety standards.

FAQ's of Trustizumab 440 mg:

Q: How should Trustizumab 440 mg (VIVITRA) be administered?

A: Trustizumab 440 mg must be reconstituted with sterile water and administered via intravenous infusion. The initial dose should be given over 90 minutes, with subsequent doses administered over 30 minutes as per your healthcare provider's instructions.

Q: What precautions must healthcare providers follow during VIVITRA therapy?

A: Cardiac function should be regularly monitored during treatment, as Trustizumab may affect heart performance. It is also contraindicated in patients with hypersensitivity to trastuzumab or its excipients.

Q: When is Trustizumab (VIVITRA) indicated for use?

A: VIVITRA is approved for the treatment of HER2-positive breast cancer and metastatic gastric cancer in adults based on a physician's prescription.

Q: Where should Trustizumab 440 mg be stored before use?

A: Store the vial at a temperature between 2C and 8C. Do not freeze. Always keep the product in its original white and purple sealed box to ensure safety and stability.

Q: What are the advantages of VIVITRA's multi-dose vial format?

A: The multi-dose vial allows for optimal usage across multiple infusions, reducing wastage and improving hospital inventory management.

Q: How does one access samples or place an order for Trustizumab 440 mg in India?

A: Registered hospitals, retailers, suppliers, and wholesalers can place orders or request samples through approved distribution channels. Documentation and certifications are provided with every dispatch.

Tell us about your requirement